Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 22 - Sep 27
How a blockbuster treatment for diabetes and obesity might slow or stop Parkinsons Oct
A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence
As GLP-1 therapies gained approval for obesity, prescribing began to diffuse beyond endocrinology into primary care, obesity medicine, and digital health platforms
Underneath all of this is the fear of stroke
In December 2011, the show was among the podcasts honored by Apple in its App Store Rewind 2011, winning in the Best New Audio Podcast category
US$ 28.60
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
US$ 23.88
US$ 27.59
US$ 28.16
:max_bytes(150000):strip_icc()/GettyImages-1259158436-1a2fd7f2794d4b4a9bedca6422346548.jpg)
